- Is it Time to Sell/Buy Cleveland BioLabs Inc. (CBLI) Stock After Recent Trade?
- Horizon Therapeutics Public Limited Company (HZNP) is up 105.28% this year
- X Financial (XYF) Stock Price Stood at $1.11 on Tuesday, October 20, What You Think?
- 12-month Target Price for Tivity Health Inc. (TVTY) Reaches at $18.64
- Weidai Ltd. (WEI) Surged 526.45%, Can Traders Take Benefit?
Titterton Lewis H jr, the Director of Anixa Biosciences Inc., bought 24500.0 shares at the valuation of $2.27 during an exchange that occurred on Jun 16, which implies that Titterton Lewis H jr is holding 980,326 shares at the estimation of $55,615 dependent on the most recent closing price.
In another transaction, on Jun 15, Director of Anixa Biosciences Inc., Titterton Lewis H jr, bought 31083.0 shares at the price of $2.27. After this activity, Titterton Lewis H jr now keeps 955,826 shares of Anixa Biosciences Inc., esteemed at $70,558 with the most recent shutting price.
ANIX Recent Trade
The share price of ANIX descended by -$0.29 during the exchanging session on 07/13/20 to exchange at $3.01. Anixa Biosciences Inc. stock has an exchanging volume of 0.46 million shares, which is high, contrasted with its 3-months average volume of 421.30K shares. Its market capitalization has now reached to $62.67M.
ANIX Past Trading Activity
The market tends to become urbane often, in any event, for prepared investors and traders. In any event, when a merchant got what he/she had expected, the market occasionally chooses to move the other way. This instability leads a few traders questioning and re-thinking their moves. This is the reason becoming acquainted with past price performance, just as both long and short time period, is significant. If we look the past performance, during the last one week, ANIX price has dropped by -1.63%. In the course of past three months sees the stock go up around 70.06%, while it has gain 4.88% over the past six months and -8.23% since the start of the year.
ANIX Earning History
Earnings per share are the amount of profit that a company produces during a specific period, which is usually defined as a quarter (three calendar months) or a year. In recent quarter of (Jul 2020), Anixa Biosciences Inc. posted -$0.12 earnings per share (EPS) which was same as the consensus estimate of -$0.12 by $0, which represents to a reduction by 0.00%.
ANIX Price Performance
Let us presently take a gander at a portion of its probable help and opposition resistance. Late research on Anixa Biosciences Inc. has seen its stock exchanging -21.61% underneath its three-month high price. A glance at the opposite side additionally observes stock exchanging +77.06% above its three-month low. A more extensive look sees ANIX exchanging -44.77% beneath its 52-week high and 126.32% above from its 52-week low price.
ANIX Instability & Beta Factor
The Volatility of a stock means that the stock’s drop or increase in the event that the more extensive market drops or rushes. A beta score higher than 1 implies that a stock is profoundly unpredictable while underneath 1 implies that the Volatility of a stock is low. If we look trading Volatility. Its 7-day Volatility is around 8.44%, while it has a month to month instability of 13.07%. The company has an ATR (Average True Range) of 0.32 and a beta factor of 1.65.